Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.
Andreas RilligChristina MagnussenAnn-Kathrin OzgaAnna SulingAxel BrandesGuenter BreithardtAlan John CammHarry J G M CrijnsLars EckardtArif ElvanAndreas GoetteMichele GuliziaLaurent HaegeliHein HeidbuchelKarl-Heinz KuckGhulam Andre NgLukasz SzumowskiIsabelle van GelderKarl WegscheiderPaulus F KirchhofPublished in: Circulation (2021)
Rhythm control therapy conveys clinical benefit when initiated within 1 year of diagnosing atrial fibrillation in patients with signs or symptoms of heart failure. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01288352. URL: http://www.controlled-trials.com; Unique identifier: ISRCTN04708680. URL: https://www.clinicaltrialsregister.eu; Unique identifier: 2010-021258-20.
Keyphrases
- atrial fibrillation
- heart failure
- left atrial
- catheter ablation
- oral anticoagulants
- left ventricular
- heart rate
- left atrial appendage
- direct oral anticoagulants
- acute heart failure
- percutaneous coronary intervention
- blood pressure
- coronary artery disease
- physical activity
- stem cells
- acute coronary syndrome
- bone marrow
- venous thromboembolism